Lunch Program: Clinical Trial Advances and Practice Integration: Translating Evidence into Patient Care
Sponsored by J&J MedTech.
The goal of this program is to discuss the clinical evidence informing best practices in high-risk PCI, heart failure, cardiogenic shock, and management with Impella technology, with a focus on translating evolving data into consistent, high-quality care.
Panel Discussion
Babar B Basir, DO, FSCAI, Henry Ford Health System, Detroit, MI, Alexandra J. Lansky, M.D., MSCAI, Yale University, New Haven, CT, Sanjit S. Jolly, M.D., McMaster University, Hamilton, ON, Canada and Norman Mangner, Technische Universität Dresden